# Emdogain Adjunctive to Autotransplantation

> **NCT06250088** · PHASE4 · RECRUITING · sponsor: **Universidad Complutense de Madrid** · enrollment: 20 (estimated)

## Conditions studied

- Autotransplantation
- Emdogain
- Autologous Transplantation
- Enamel Matrix Derivatives

## Interventions

- **BIOLOGICAL:** Emdogain (EMD) - test
- **PROCEDURE:** Sham group

## Key facts

- **NCT ID:** NCT06250088
- **Lead sponsor:** Universidad Complutense de Madrid
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-03-12
- **Primary completion:** 2025-06-01
- **Final completion:** 2026-03-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2024-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06250088

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06250088, "Emdogain Adjunctive to Autotransplantation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06250088. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*